Equity
€449,274 ▲ 26.6%
SEPHALIN has made a profit in every financial year since 2019.
SEPHALIN
Lifetime
7 annual accounts with figures on one time axispeak €189,734 (2021)
€170,817▼ 0.8%
peak €109,781 (2023)
€94,283▲ 208%
peak €449,274 (2025)
€449,274▲ 26.6%
€1.1m▼ 9.3%
peak 1.6 FTE (2023)
0.2 FTE▼ 84.6%
Board1 name since 2018
1 director
Documentsfilings and deeds
31-08-202631 days late
2025abbreviated format
Result from €30,658 to €94,283Staff from 1.3 FTE to 0.2 FTEEquity from €354,991 to €449,274Cash from €11,659 to €3,619
Key points
from the 2025 annual accountsResult
€94,283 ▲ 208%
The result rose in 2025 from €30,658 to €94,283.
Turnover
≈ €800,000 estimated
The abbreviated format states no turnover.
Debts
€1.1m 72% of the balance sheet
Financial debts 80%Suppliers 0%Taxes and wages 1%Other 18%
€326,700 of the debts are secured on the company's own assets. In 2021 that was €471,900.
Filings
7 annual accounts 7 late
The 2019 accounts came latest: 34 days after the end of the period.
Starting capital
€20,000 20 shares
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0712968905
Registered office moved to Veurne
New registered office: Noordstraat38, 8630 Veurne · Previous registered office: Kerkhofstraat16, Koksijde (Oostduinkerke) · Change of role: , from manager to director · General meeting of 21-12-2023 · Gazette deed
First establishment
Kerkhofstraat 16, Koksijde
Incorporation
Founding capital of €20,000, 20 shares · Founder: · Appointment: (manager) · published on 12-11-2018 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| SEPHALIN Veurne | €1.6m | €170,817 | 28.2% | 0.2 |
| Duchi-Naert Harelbeke | €1.5m | €156,005 | 38.2% | 0 |
| Pharmacie de Lincent Lincent | €1.3m | €125,818 | 10.1% | 0.3 |
| Racha NAIM Saint-Nicolas | €1.2m | €148,214 | 27.6% | 0 |
| DEGROFARM Deinze | €1.5m | €113,527 | 10.2% | 0 |
| PHARMAKES Ypres | €1.6m | €185,328 | 68.7% | 0 |
| APOTHEEK SINT-IDESBALD Koksijde | €1.1m | €231,939 | 38.7% | 0 |
These companies have the same main activity as SEPHALIN: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.1m and €1.6m, founded between 2012 and 2019.
Official details
Source: KBO- Status
- Active since 08-11-2018Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Joint committee
- 313Pharmacies and pricing offices · annual accounts 2025
- Establishment unit
- 2.282.581.1358670 Koksijde, since 01-01-2019
- Financial year end
- 31 December
- Peppol
- Reachable since 25-11-2025
Insights on SEPHALIN
SEPHALIN files the abbreviated format. That format states no turnover. The gross margin rose from €80,390 in 2019 to €170,817 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about SEPHALIN
- What is the company number of SEPHALIN?
- The company number of SEPHALIN is 0712.968.905. The VAT number is the same number with BE in front: BE 0712.968.905.
- Where is SEPHALIN based?
- The registered office is at Noordstraat 38, 8630 Veurne.Company details
- What does SEPHALIN do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of SEPHALIN?
- SEPHALIN is a private limited company (BV).
- When was SEPHALIN founded?
- SEPHALIN was founded on 08-11-2018.
- Is SEPHALIN still active?
- Yes, SEPHALIN is an active enterprise in the KBO register.
- How many employees does SEPHALIN have?
- SEPHALIN had an average of 0.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does SEPHALIN fall under?
- In its 2025 annual accounts, SEPHALIN states joint committee 313 (Pharmacies and pricing offices).
- What is the turnover of SEPHALIN?
- The turnover in financial year 2025 is ≈ €800,000. This figure is estimated from the gross margin of €170,817 and 51 comparable companies (NACE 477). It probably lies between €530,000 and €1.5m.
- Is SEPHALIN profitable?
- In financial year 2025, SEPHALIN made a profit of €94,283.
- Where can I find the annual accounts of SEPHALIN?
- SEPHALIN filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of SEPHALIN due?
- SEPHALIN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.